Oppenheimer has recently initiated Corvus Pharmaceuticals Inc (CRVS) stock to Outperform rating, as announced on August 18, 2023, according to Finviz. Earlier, on December 1, 2021, Jefferies had ...
Some results have been hidden because they may be inaccessible to you